+

US9353060B2 - Process for the preparation of 3-hydroxypicolinic acids - Google Patents

Process for the preparation of 3-hydroxypicolinic acids Download PDF

Info

Publication number
US9353060B2
US9353060B2 US14/793,251 US201514793251A US9353060B2 US 9353060 B2 US9353060 B2 US 9353060B2 US 201514793251 A US201514793251 A US 201514793251A US 9353060 B2 US9353060 B2 US 9353060B2
Authority
US
United States
Prior art keywords
formula
compound
mixture
acid
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US14/793,251
Other languages
English (en)
Other versions
US20160009647A1 (en
Inventor
James M. Renga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corteva Agriscience LLC
Original Assignee
Dow AgroSciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow AgroSciences LLC filed Critical Dow AgroSciences LLC
Priority to US14/793,251 priority Critical patent/US9353060B2/en
Publication of US20160009647A1 publication Critical patent/US20160009647A1/en
Assigned to DOW AGROSCIENCES LLC reassignment DOW AGROSCIENCES LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: RENGA, JAMES M.
Application granted granted Critical
Publication of US9353060B2 publication Critical patent/US9353060B2/en
Assigned to CORTEVA AGRISCIENCE LLC reassignment CORTEVA AGRISCIENCE LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: DOW AGROSCIENCES LLC
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/803—Processes of preparation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Definitions

  • the present disclosure concerns a process for the preparation of 4-alkoxy-3-hydroxypicolinic acids. More particularly, the present disclosure concerns a process for the preparation of 4-alkoxy-3-hydroxypicolinic acids from 2-substituted furans.
  • the present disclosure concerns a process for the preparation of a compound of Formula A
  • the compound of Formula A is useful in processes to prepare 4-alkoxy-3-hydroxypicolinic acids of Formula
  • the compound of Formula A is prepared in a process that comprises the following steps:
  • the compound of Formula B is prepared in a process that comprises the following steps:
  • the compound of Formula B may also be prepared in a process that comprises the following steps:
  • the Lewis acid used in the process is boron trifluoride etherate.
  • the acid cleavable group is a benzyl group.
  • the strong acid used in the process is at least one acid selected from the group consisting of hydrochloric acid and hydrobromic acid.
  • Another aspect of the present disclosure is a novel intermediate produced in the present process, viz., the compound consisting of:
  • R 2 is a C 1 -C 4 alkyl.
  • isolated means to partially or completely remove the desired product from the other components of a finished chemical process mixture using standard methods such as, but not limited to, filtration, extraction, distillation, crystallization, centrifugation, trituration, liquid-liquid phase separation or other methods known to those of ordinary skill in the art.
  • the isolated product may have a purity that ranges from ⁇ 50% to ⁇ 50%, and may be purified to a higher purity level using standard purification methods.
  • the isolated product may also be used in a subsequent process step with or without purification.
  • Cyano(furan-2-yl)methanaminium halide salts of Formula 1a have been prepared and used as intermediates in the preparation of 3-hydroxypicolinonitriles and 3-hydroxy-picolinoamides of Formula 1b as described in Acta Chem. Scand. 19 (1965), pg. 1147-1152,
  • R 2 is H or methyl
  • R 3 is H or 2-propyl
  • R 4 is CN or C(O)NH 2 .
  • 4,6-dibromo-3-hydroxypicolinate esters of Formula A are prepared from alkyl 2-amino-2-(furan-2-yl)acetate hydrohalide salts of Formula B in one chemical step by use of a bromination-rearrangement reaction.
  • the starting furan compound of Formula B as either the HCl or HBr salt and where R 2 represents a C 1 -C 4 alkyl, is treated with a suitable brominating agent such as bromine, 1,3-dibromo-5,5-dimethylhydantoin or N-bromosuccinimide.
  • the reaction is preferably conducted using about 4 molar equivalents of bromine. It may be convenient to use an excess of the brominating agent such as a 5%,
  • a base is used in the reaction and may be selected from sodium acetate or potassium acetate and the like.
  • the reaction is preferably carried out in a protic solvent or reaction medium such as water, or mixtures of water and an alcohol such as, methanol or ethanol.
  • the temperature at which the reaction is conducted is between about 0° C. and about 10° C., preferably between about 0° C. and about 5° C.
  • the reaction mixture is allowed to warm to room temperature and stir there for 15-48 hours. After the reaction is complete, the desired product is recovered by employing standard isolation and purification techniques.
  • the alkyl 2-amino-2-(furan-2-yl)acetate hydrohalide salt of Formula B may be prepared by the two chemical processes shown in Scheme 1.
  • Path A 2-(furan-2-yl)-2-oxoacetic acid (Formula C) is first converted into the O-alkyl oxime ester of Formula E (chemical steps a and b), as described in Chemical Research in Toxicology, 24(5) 706-717 (2011) and in PCT Int. Application 2005111001 (2005), and then E is converted into the halide salt of Formula B (chemical steps c and d).
  • Path B the alkyl 2-methoxy-2-(N-carboxyalkylamino)acetate of
  • the O-alkyl oxime ester of Formula E is prepared (chemical steps a and b) by first combining together an O-alkyl-hydroxylamine hydrohalide salt, 2-(furan-2-yl)-2-oxoacetic acid (Formula C), a base and a solvent, and heating the resulting mixture to produce the oxime acid of Formula D.
  • From one to about three molar equivalents of the O-alkyl-hydroxylamine hydrohalide salt (R 3 is a C 1 -C 4 alkyl) and from about two to about six molar equivalents of the base may be used in this reaction.
  • Suitable bases include trialkylamines, alkali metal carbonates such as sodium carbonate or potassium carbonate, and the like.
  • Suitable solvents include alcohols such as methanol, ethanol or 2-propanol.
  • the present reaction is typically conducted with agitation sufficient to maintain an essentially uniform mixture of the reactants and generally requires from about 1 to about 10 hours, preferably
  • the reaction is usually conducted at between about 25° C. and about 85° C., preferably between about 45° C. and about 65° C.
  • the oxime acid of Formula D is recovered by employing standard isolation and purification techniques.
  • the O-alkyl oxime acid of Formula D is then converted into the ester of Formula E by esterification in an alcohol solvent in the presence of an acid or an acid-forming compound.
  • Suitable alcohol solvents include C 1 -C 4 alcohols such as, for example, methanol, ethanol, 1-propanol and 1-butanol.
  • Suitable acids include strong acids such as anhydrous hydrochloric acid, sulfuric acid or p-toluenesulfonic acid, and suitable acid-forming compounds include carboxylic acid halides such as acetyl chloride, acetyl bromide, propionyl chloride or propionyl bromide, and the like.
  • From 0.01 to about 2.0 molar equivalents of the acid or acid forming compound may be used.
  • the reaction is usually conducted at between about 25° C. and about 85° C., preferably between about 45° C. and about 65° C. for a period of about 8 to about 48 hours, preferably for about 12 to about 24 hours.
  • the oxime ester of Formula E is recovered by employing standard isolation and purification techniques.
  • the O-alkyl oxime ester of Formula E is then converted to the aminoester of Formula F by reduction with zinc dust (chemical step c).
  • This reaction is normally conducted in an alcohol solvent containing 50% aqueous formic acid. Suitable volume ratios of the alcohol solvent to the 50% aqueous formic acid are from about 4:1 to about 1:1, preferably from about 2:1 to about 1:1.
  • Suitable alcohol solvents include C 1 -C 4 alcohols such as, for example, methanol, ethanol, 1-propanol and 1-butanol, preferably, methanol may be used. From about 2 to about 4 molar equivalents of zinc dust are normally used and the reduction is normally run at 0-10° C. for 0.5 to about 2 hours and then at room temperature for about 12 to about 48 hours.
  • the aminoester F is recovered by employing standard isolation and purification techniques.
  • Aminoester F is then converted to the halide salt of Formula B by treatment with a strong acid such as hydrochloric acid, hydrobromic acid or sulfuric acid.
  • a strong acid such as hydrochloric acid, hydrobromic acid or sulfuric acid.
  • From about 2 to about 6 molar equivalents of the strong acid may be used and may be added to a solution of aminoester F in a water immiscible solvent such as diethyl ether, methyl t-butyl ether, 2-methyl furan, dioxane, and the like.
  • the strong acid is normally used in an anhydrous form such as a solution in a non-aqueous solvent such as, for example, acetic acid or dioxane.
  • the strong acid may also be added to the process in the form of a gas or a neat liquid.
  • the strong acid is normally added to aminoester F at from about 0° C. to about room temperature, and the resulting mixture then conducted for about 0.5 to about 2.0 hours
  • the 2-methoxyaminoacid derivative of Formula G is coupled with furan in the presence of a Lewis acid to provide the 2-substituted furan of Formula H.
  • the compound of Formula G wherein R 2 is a C 1 -C 4 alkyl and R 4 is an acid cleavable group selected from allyl, benzyl or a substituted allyl or benzyl group, is placed in a solvent and then treated at room temperature with the Lewis acid, followed immediately by the addition of furan.
  • Suitable solvents for use in this reaction include diethyl ether, methyl t-butyl ether, 2-methyl furan, dioxane, and the like.
  • Suitable Lewis acids include boron trifluoride etherate, aluminum trichloride, tin tetrachloride, and the like. Relative to compound G, from about 1.0-2.0, preferably from about 1.2-1.7, molar equivalents of the Lewis acid and from about 2.0-6.0, preferably from about 3.0-5.0, molar equivalents of furan are typically used in this coupling reaction. The reaction is typically conducted for about 10 hours to about 48 hours, preferably for about 18 to about 32 hours at room temperature. After the reaction is complete, the 2-substituted furan of Formula H is recovered by employing standard isolation and purification techniques.
  • the compound of Formula H is converted to the compound of Formula B by treatment with a strong acid, such as, hydrochloric acid, hydrobromic acid or sulfuric acid, at room temperature in a polar, carboxylic acid solvent such as acetic acid, propionic acid, and the like. From about 2.0 to about 7.0, preferably from about 4.0 to about 6.0, molar equivalents of the strong acid may be used.
  • the reaction is conducted for about 0.25 to about 5.0 hours, preferably for about 0.5 to about 2 hours at room temperature.
  • the 2-substituted furan of Formula B is recovered by employing standard isolation and purification techniques.
  • Example 2a The crude 2-(furan-2-yl)-2-(methoxyimino)acetic acid (Example 2a) was dissolved in 100 mL of MeOH and was added to a solution of acetyl chloride (3.82 ml, 53.5 mmol) in 50 mL of MeOH. After refluxing for 16 hr, solvent was removed on the rotary evaporator and the crude product was added to 100 mL EtOAc and 20 mL of water.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
US14/793,251 2014-07-08 2015-07-07 Process for the preparation of 3-hydroxypicolinic acids Active US9353060B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/793,251 US9353060B2 (en) 2014-07-08 2015-07-07 Process for the preparation of 3-hydroxypicolinic acids

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462021868P 2014-07-08 2014-07-08
US14/793,251 US9353060B2 (en) 2014-07-08 2015-07-07 Process for the preparation of 3-hydroxypicolinic acids

Publications (2)

Publication Number Publication Date
US20160009647A1 US20160009647A1 (en) 2016-01-14
US9353060B2 true US9353060B2 (en) 2016-05-31

Family

ID=55064780

Family Applications (1)

Application Number Title Priority Date Filing Date
US14/793,251 Active US9353060B2 (en) 2014-07-08 2015-07-07 Process for the preparation of 3-hydroxypicolinic acids

Country Status (15)

Country Link
US (1) US9353060B2 (fr)
EP (1) EP3166928B1 (fr)
JP (1) JP6560335B2 (fr)
KR (1) KR102418462B1 (fr)
CN (1) CN106660959B (fr)
AR (1) AR101136A1 (fr)
BR (1) BR112016030604B8 (fr)
CA (1) CA2954268C (fr)
CO (1) CO2017000010A2 (fr)
ES (1) ES2726927T3 (fr)
IL (1) IL249794B (fr)
MX (1) MX387903B (fr)
TW (1) TWI689495B (fr)
WO (1) WO2016007532A1 (fr)
ZA (1) ZA201700034B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024018354A1 (fr) 2022-07-18 2024-01-25 Pi Industries Ltd. Procédé de synthèse d'acides 4-alcoxy-3-hydroxypicoliniques et de leurs intermédiaires

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10550083B2 (en) * 2016-01-22 2020-02-04 Dow Agrosciences Llc Processes for the preparation of 4-alkoxy-3-hydroxypicolinic acids
TW201733985A (zh) * 2016-02-29 2017-10-01 陶氏農業科學公司 用於製備4-烷氧基-3-羥基吡啶甲酸之方法
US10403145B2 (en) * 2017-01-19 2019-09-03 Ford Global Technologies, Llc Collison mitigation and avoidance
JP2020161992A (ja) 2019-03-27 2020-10-01 ソニーセミコンダクタソリューションズ株式会社 撮像システム及び物体認識システム

Citations (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406905A (en) 1980-07-28 1983-09-27 Ciba-Geigy Corporation 2-Pyridyl-2-thiazoline-4-carboxylic acid derivatives
US4506084A (en) 1981-03-19 1985-03-19 Imperial Chemical Industries Plc Aminonitrile intermediates
WO2001014339A2 (fr) 1999-08-20 2001-03-01 Dow Agrosciences Llc Amides aromatiques heterocycliques fongicides et leurs compositions, mode d'emploi et preparation
US6355660B1 (en) 1999-07-20 2002-03-12 Dow Agrosciences Llc Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
US20020177578A1 (en) 1999-07-20 2002-11-28 Ricks Michael J. Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
US6521622B1 (en) * 1999-07-20 2003-02-18 Dow Agrosciences Llc Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
US6743804B2 (en) * 1995-11-24 2004-06-01 Smithkline Beecham S P.A. Quinoline derivatives as NK3 antagonists
US20040171838A1 (en) 2001-07-31 2004-09-02 Meyer Kevin Gerald Reductive cleavage of the exocyclic ester of uk-2a or its derivatives and products formed therefrom
US20040186296A1 (en) 2001-10-05 2004-09-23 Niyaz Noormohamed Mohamed Process to produce derivatives from uk-2a derivatives
US20040192924A1 (en) 2001-10-23 2004-09-30 Meyer Kevin Gerald Derivatives of uk-2a
EP1516874A1 (fr) 1999-07-20 2005-03-23 Dow AgroSciences LLC Amides aromatiques fongicides hétérocycliques, leurs compositions, procédés d'utilisation et de préparation
US20050176767A1 (en) 2003-10-30 2005-08-11 Laval Chan Chun Kong Pyridine carboxamide and methods for inhibiting HIV integrase
US20050239873A1 (en) 1999-08-20 2005-10-27 Fred Hutchinson Cancer Research Center 2 Methoxy antimycin a derivatives and methods of use
US7183278B1 (en) 1998-11-04 2007-02-27 Meiji Seika Kaisha, Ltd. Picolinamide derivative and harmful organism control agent comprising said picolinamide derivative as active component
US20070060579A1 (en) 2003-10-10 2007-03-15 Ulrike Wachendorff-Neumann Synergistic fungicidal active substance combinations
US20070066629A1 (en) 2003-05-28 2007-03-22 Tormo I Blasco Jordi Fungicidal mixtures for controlling rice pathogens
US7250389B1 (en) 1998-02-06 2007-07-31 Meiji Seika Kaisha, Ltd. Antifungal compound and process for producing the same
WO2009040397A1 (fr) 2007-09-26 2009-04-02 Basf Se Compositions fongicides ternaires comprenant du boscalide et du chlorothalonil
US20090306142A1 (en) 2008-05-30 2009-12-10 Dow Agrosciences Llc METHODS TO CONTROL QoI-RESISTANT FUNGAL PATHOGENS
US20110053966A1 (en) 2009-09-01 2011-03-03 Dow Agrosciences Llc Synergistic fungicidal compositions containing a 5-fluoropyrimidine derivative for fungal control in cereals
US20110082162A1 (en) 2009-10-07 2011-04-07 Dow Agrosciences Llc Synergistic fungicidal composition containing 5-fluorocytosine for fungal control in cereals
WO2012070015A1 (fr) 2010-11-24 2012-05-31 Stemergie Biotechnology Sa Inhibiteurs de l'activité du complexe iii de la chaîne mitochondriale de transfert des électrons et utilisation de ceux-ci pour traiter des maladies
US20120245031A1 (en) 2009-12-08 2012-09-27 Basf Se Pesticidal Mixtures
US20130296371A1 (en) 2012-05-07 2013-11-07 Dow Agrosciences Llc Macrocyclic picolinamides as fungicides
US20130296373A1 (en) 2012-05-07 2013-11-07 Dow Agrosciences Llc Macrocyclic picolinamides as fungicides
US20140128411A1 (en) 2011-07-08 2014-05-08 Ishihara Sangyo Kaisha, Ltd. Fungicidal composition and method for controlling plant diseases
US20140187588A1 (en) 2012-12-31 2014-07-03 Dow Agrosciences Llc Macrocyclic picolinamides as fungicides
US20140187587A1 (en) 2012-12-28 2014-07-03 Dow Agrosciences Llc Synergistic fungicidal mixtures for fungal control in cereals
US8785479B2 (en) 2012-05-07 2014-07-22 Dow Agrosciences, Llc. Macrocyclic picolinamides as fungicides
US8883811B2 (en) 2009-10-07 2014-11-11 Dow Agrosciences, Llc. Synergistic fungicidal mixtures for fungal control in cereals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133447A (en) * 1998-02-27 2000-10-17 Novartis Crop Protection, Inc. Process for the preparation of substituted pyridines
ES2295068T3 (es) * 1999-11-24 2008-04-16 MERCK & CO., INC. Gamma-hidroxi-2-(fluoroalquilaminocarbonil)-1-piperazinpentanamidas como inhibidores de la proteasa del vih.
US20070275954A1 (en) * 2004-05-19 2007-11-29 Astrazeneca Ab Novel Fused Heterocycles and Uses Thereof
JP2009533435A (ja) * 2006-04-11 2009-09-17 メルク エンド カムパニー インコーポレーテッド ジアリール置換アルカン
NZ593536A (en) * 2008-12-19 2013-07-26 Genentech Inc Quinoline derivatives and methods of use

Patent Citations (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406905A (en) 1980-07-28 1983-09-27 Ciba-Geigy Corporation 2-Pyridyl-2-thiazoline-4-carboxylic acid derivatives
US4506084A (en) 1981-03-19 1985-03-19 Imperial Chemical Industries Plc Aminonitrile intermediates
US6743804B2 (en) * 1995-11-24 2004-06-01 Smithkline Beecham S P.A. Quinoline derivatives as NK3 antagonists
US7250389B1 (en) 1998-02-06 2007-07-31 Meiji Seika Kaisha, Ltd. Antifungal compound and process for producing the same
US7183278B1 (en) 1998-11-04 2007-02-27 Meiji Seika Kaisha, Ltd. Picolinamide derivative and harmful organism control agent comprising said picolinamide derivative as active component
US20020177578A1 (en) 1999-07-20 2002-11-28 Ricks Michael J. Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
US20030018012A1 (en) 1999-07-20 2003-01-23 Ricks Michael J. Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
US20030022902A1 (en) 1999-07-20 2003-01-30 Ricks Michael J. Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
US6521622B1 (en) * 1999-07-20 2003-02-18 Dow Agrosciences Llc Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
US20040034025A1 (en) 1999-07-20 2004-02-19 Ricks Michael J. Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
US20040048864A1 (en) 1999-07-20 2004-03-11 Ricks Michael J. Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
US6706740B2 (en) 1999-07-20 2004-03-16 Dow Agrosciences Llc Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
US20030018052A1 (en) 1999-07-20 2003-01-23 Ricks Michael J. Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
EP1516874A1 (fr) 1999-07-20 2005-03-23 Dow AgroSciences LLC Amides aromatiques fongicides hétérocycliques, leurs compositions, procédés d'utilisation et de préparation
US7034035B2 (en) 1999-07-20 2006-04-25 Dow Agrosciences Llc Fungicidal mono-, bi-, and tri-cycloheteroalkyl amides and their compositions, methods of use and preparation
US6355660B1 (en) 1999-07-20 2002-03-12 Dow Agrosciences Llc Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
US6927225B2 (en) 1999-07-20 2005-08-09 Dow Agrosciences Llc Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation
US20050239873A1 (en) 1999-08-20 2005-10-27 Fred Hutchinson Cancer Research Center 2 Methoxy antimycin a derivatives and methods of use
WO2001014339A2 (fr) 1999-08-20 2001-03-01 Dow Agrosciences Llc Amides aromatiques heterocycliques fongicides et leurs compositions, mode d'emploi et preparation
US20040171838A1 (en) 2001-07-31 2004-09-02 Meyer Kevin Gerald Reductive cleavage of the exocyclic ester of uk-2a or its derivatives and products formed therefrom
US20040186296A1 (en) 2001-10-05 2004-09-23 Niyaz Noormohamed Mohamed Process to produce derivatives from uk-2a derivatives
US6861390B2 (en) 2001-10-23 2005-03-01 Dow Agrosciences Llc Derivatives of UK-2A
US20040192924A1 (en) 2001-10-23 2004-09-30 Meyer Kevin Gerald Derivatives of uk-2a
US20070066629A1 (en) 2003-05-28 2007-03-22 Tormo I Blasco Jordi Fungicidal mixtures for controlling rice pathogens
US20070060579A1 (en) 2003-10-10 2007-03-15 Ulrike Wachendorff-Neumann Synergistic fungicidal active substance combinations
US20050176767A1 (en) 2003-10-30 2005-08-11 Laval Chan Chun Kong Pyridine carboxamide and methods for inhibiting HIV integrase
WO2009040397A1 (fr) 2007-09-26 2009-04-02 Basf Se Compositions fongicides ternaires comprenant du boscalide et du chlorothalonil
US20090306142A1 (en) 2008-05-30 2009-12-10 Dow Agrosciences Llc METHODS TO CONTROL QoI-RESISTANT FUNGAL PATHOGENS
US20110053966A1 (en) 2009-09-01 2011-03-03 Dow Agrosciences Llc Synergistic fungicidal compositions containing a 5-fluoropyrimidine derivative for fungal control in cereals
US8883811B2 (en) 2009-10-07 2014-11-11 Dow Agrosciences, Llc. Synergistic fungicidal mixtures for fungal control in cereals
US20110082162A1 (en) 2009-10-07 2011-04-07 Dow Agrosciences Llc Synergistic fungicidal composition containing 5-fluorocytosine for fungal control in cereals
US20150065529A1 (en) 2009-10-07 2015-03-05 Dow Agrosciences Llc Synergistic fungicidal mexures for fungal control in cereals
US20120245031A1 (en) 2009-12-08 2012-09-27 Basf Se Pesticidal Mixtures
WO2012070015A1 (fr) 2010-11-24 2012-05-31 Stemergie Biotechnology Sa Inhibiteurs de l'activité du complexe iii de la chaîne mitochondriale de transfert des électrons et utilisation de ceux-ci pour traiter des maladies
US20140128411A1 (en) 2011-07-08 2014-05-08 Ishihara Sangyo Kaisha, Ltd. Fungicidal composition and method for controlling plant diseases
US8785479B2 (en) 2012-05-07 2014-07-22 Dow Agrosciences, Llc. Macrocyclic picolinamides as fungicides
US8835462B2 (en) 2012-05-07 2014-09-16 Dow Agrosciences, Llc. Macrocyclic picolinamides as fungicides
US20140275171A1 (en) 2012-05-07 2014-09-18 Dow Agrosciences Llc Macrocyclic picolinamides as fungicides
US20130296373A1 (en) 2012-05-07 2013-11-07 Dow Agrosciences Llc Macrocyclic picolinamides as fungicides
US20130296371A1 (en) 2012-05-07 2013-11-07 Dow Agrosciences Llc Macrocyclic picolinamides as fungicides
US20140187587A1 (en) 2012-12-28 2014-07-03 Dow Agrosciences Llc Synergistic fungicidal mixtures for fungal control in cereals
US20140187588A1 (en) 2012-12-31 2014-07-03 Dow Agrosciences Llc Macrocyclic picolinamides as fungicides

Non-Patent Citations (18)

* Cited by examiner, † Cited by third party
Title
Anonymous, Synergistic Fungicidal Composition of Heterocyclic Aromatic Amides and Triazoles, IP.Com Journal, IP.Com, Inc., West Henrietta, NY, US, Dated Jul. 2004, 10 pages.
Anonymous, Synergistic Fungicidal Composition of Heterocyclic Aromatic Amides and Triazoles, IP.Com, Electronic Publication, 2004, 11 pages.
Baruah, P.K, et al., "Synthesis, anticonvulsant activity, and neuropathic pain attenuating activity of N-benzyl 2-amino-2-(hetero)aromatic acetamides," Bioorganic & Medicinal Chemistry 20, (2012) 3551-3564.
BASF new fungicide Xemium got full approval in EU. AgroNews. Jul. 18, 2012 [retrieved on 1-20 Feb. 4, 2014). Retrieved from the Internet: .
BASF new fungicide Xemium got full approval in EU. AgroNews. Jul. 18, 2012 [retrieved on 1-20 Feb. 4, 2014). Retrieved from the Internet: <URL: http://news.agropages.com/News/NewsDetail-7386.htm>.
Clauson-Kass, N., et al, "Preparation of Derivatives of 3-Hydroxypicolinic Acid from Furfural", Acta Chemica Scandinavica, 1965, vol. 199, pp. 1147-1152.
Demir, A.S., et al, "An asymmetric sythesis of both enantiomers of 2,2,2-trifluror-1-furan-2-yl-ethylamine and 3,3,3-trifluoroalanine from 2,2,2-trifluroro-1-furan-2-yl-ethanone," Tetrahedron: Asymmetry 12 (2001) 2309-2313.
Gisi, U. The American Phytopathological Society, vol. 86, No. 11, 1996, P. 1273-79.
Goldberg, AA, et al., "254. Synthesis of Omega-Aminoalkyl Cyanides" Journal of the Chemical Society, 1947, pp. 1369-1371.
Guo-Qiang Shi, "delta, epsilon-Unsaturated beta,beta-Difluroro-alpha-keto Esters: Novel Synthesis and Utility as Precursors of beta,beta-Difluoro-alpha-amino Acids," Journal Organic Chemistry, 1995, 60 pp. 6289-6295.
International Searching Authority, International Search Report for PCT/US15/39411, dated Oct. 6, 2015, 3 pages.
International Searching Authority, Written Opinion for PCT/US15/39411, dated Oct. 6, 2015, 7 pages.
K. Tani, et al., Journal of Antibiotics, vol. 55, No. 3, Mar. 2002, pp. 315-321.
Kissling, Crop Protection pipeline value jumps to 2.4 billion. BASF. Mar. 11, 2010, pp. 1-4, [retrieved on Feb. 4, 2014]. Retrieved from the Internet: <URL: http://www.agro.basf.com/agr/AP-Internet/en/content/news-room/news/basf-crop-protection-pipaline-value>.
Kissling, Crop Protection pipeline value jumps to 2.4 billion. BASF. Mar. 11, 2010, pp. 1-4, [retrieved on Feb. 4, 2014]. Retrieved from the Internet: <URL: http://www.agro.basf.com/agr/AP-Internet/en/content/news-room/news/basf-crop-protection-pipaline-value>.
PUBCHEM-CID-11435037 Create Date: Oct. 26, 2006, 10 pages.
Y.Usuki, et al. Journal of Antibiotics, vol. 55, No. 6, Jun. 2002, pp. 607-610.
Z. Hu, et al, Synthesis of Novel Analogues of Antimycin A3, Tetrahedron Letters 49 (2008) pp. 5192-5195.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024018354A1 (fr) 2022-07-18 2024-01-25 Pi Industries Ltd. Procédé de synthèse d'acides 4-alcoxy-3-hydroxypicoliniques et de leurs intermédiaires

Also Published As

Publication number Publication date
CO2017000010A2 (es) 2017-03-31
TW201625537A (zh) 2016-07-16
EP3166928A1 (fr) 2017-05-17
AR101136A1 (es) 2016-11-23
KR20170026444A (ko) 2017-03-08
EP3166928B1 (fr) 2019-04-03
BR112016030604B1 (pt) 2021-08-24
EP3166928A4 (fr) 2018-01-10
IL249794B (en) 2020-07-30
BR112016030604A2 (pt) 2017-08-22
BR112016030604B8 (pt) 2022-08-23
TWI689495B (zh) 2020-04-01
MX2016017124A (es) 2017-05-10
ES2726927T3 (es) 2019-10-10
KR102418462B1 (ko) 2022-07-08
CA2954268A1 (fr) 2016-01-14
IL249794A0 (en) 2017-03-30
JP6560335B2 (ja) 2019-08-14
WO2016007532A1 (fr) 2016-01-14
MX387903B (es) 2025-03-19
US20160009647A1 (en) 2016-01-14
CN106660959A (zh) 2017-05-10
ZA201700034B (en) 2018-08-29
CA2954268C (fr) 2022-11-22
CN106660959B (zh) 2019-12-03
JP2017521416A (ja) 2017-08-03

Similar Documents

Publication Publication Date Title
US9353060B2 (en) Process for the preparation of 3-hydroxypicolinic acids
US9108932B2 (en) Preparation of haloalkoxyarylhydrazines and intermediates therefrom
US8884028B2 (en) Process for preparing alkyl 2-alkoxymethylene-4,4-difluoro-3-oxobutyrates
CA3083672A1 (fr) Procede de preparation de roxadustat et de ses intermediaires
JPH05331124A (ja) α−ケトアミド誘導体の製造法
US9533956B2 (en) Method of manufacturing pyridazinone compound
US8039633B2 (en) Method for producing nicotinic acid derivative or salt thereof
CA2151817C (fr) Methode de preparation d&#39;ethers d&#39;hydroxylamine et de leurs sels; produits intermediaires utiles dans ce contexte
US10562834B2 (en) Process for preparing substituted crotonic acids
US9765033B2 (en) Method for the production of 3,5-bis(fluoroalkyl)pyrazole derivatives
US20040199002A1 (en) Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor
US20160060210A1 (en) Process for the Preparation of Lacosamide and Its Novel Intermediate
US9212120B2 (en) Process for preparing spiro[2.5]octane-5,7-dione
US5498792A (en) Process of producing N-alkylacetamides
US10752586B1 (en) Process for preparation of molindone
US7915418B2 (en) Intermediates and process for the production of optically active quinolonecarboxylic acid derivatives
JP4929717B2 (ja) Ｎ，ｎ’−ジアルコキシ−ｎ，ｎ’−ジアルキルオキサミドの製法
US20130030183A1 (en) Process for preparing a pharmaceutical compound
US20250122158A1 (en) Process for preparing isoxazoline-5,5-vinylcarboxylic acid derivatives
JP2004051591A (ja) ５−ブロモ−２−アルコキシピリジンの製造方法

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

AS Assignment

Owner name: DOW AGROSCIENCES LLC, INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RENGA, JAMES M.;REEL/FRAME:037862/0094

Effective date: 20160226

STCF Information on status: patent grant

Free format text: PATENTED CASE

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 4

AS Assignment

Owner name: CORTEVA AGRISCIENCE LLC, INDIANA

Free format text: CHANGE OF NAME;ASSIGNOR:DOW AGROSCIENCES LLC;REEL/FRAME:058044/0184

Effective date: 20210101

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 8

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载